Barings BDC, Inc.: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 4, 2023 and accepted by EDGAR at May 4, 2023, 16:19 ET.
Management's discussion and analysis
As filed, 107,874 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion is designed to provide a better understanding of our Unaudited Consolidated Financial Statements for the three months ended March 31, 2023, including a brief discussion of our business, key factors that impacted our performance and a summary of our operating results. The following discussion should be read in conjunction with the Unaudited Consolidated Financial Statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q, and the Consolidated Financial Statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2022. Historical results and percentage relationships among any amounts in the financial statements are not necessarily indicative of trends in operating results for any future periods.
Forward-Looking Statements
Some of the statements in this Quarterly Report constitute forward-looking statements because they relate to future events or our future performance or financial condition. Forward-looking statements may include, among other things, statements as to our future operating results, our business prospects and the prospects of our portfolio companies, the impact of the investments that we expect to make, the ability of our portfolio companies to achieve their objectives, our expected financings and investments, the adequacy of our cash resources and working capital, and the timing of cash flows, if any, from the operations of our portfolio companies. Words such as “expect,” “anticipate,” “target,” “goals,” “project,” “intend,” “plan,” “believe,” “seek,” “estimate,” “continue,” “forecast,” “may,” “should,” “potential,” variations of such words, and similar expressions indicate a forward-looking statement, although not all forward-looking statements include these words. Readers are cautioned that the forward-looking statements contained in this Quarterly Report are only predictions, are not guarantees of future performance, and are subject to risks, events, uncertainties and assumptions that are difficult to predict. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the items discussed herein, in Item 1A entitled “Risk Factors” in Part I of our Annual Report on Form 10-K for the year ended December 31, 2022 and in Item 1A entitled “Risk Factors” in Part II of our subsequently filed Quarterly Reports on Form 10-Q or in other reports that we may file with the Securities and Exchange Commission (the “SEC”) from time to time. Other factors that could cause our actual results and financial condition to differ materially include, but are not limited to, changes in political, economic or industry conditions, including the risks of a slowing economy, rising inflation and risk of recession, and volatility in the financial services sector, including bank failures; the interest rate environment or conditions affecting the financial and capital markets; the impact of global health crises, on our or our portfolio companies’ business and the U.S. and global economies; our, or our portfolio companies’, future business, operations, operating results or prospects; risks associated with possible disruption due to terrorism in our operations or the economy generally; and future changes in laws or regulations and conditions in our or our portfolio companies’ operating areas. These statements are based on our current expectations, estimates, forecasts, information and projections about the industry in which we operate and the beliefs and assumptions of our management as of the date of filing of this Quarterly Report. We assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless we are required to do so by law. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
Overview of Our Business
We are a Maryland corporation incorporated on October 10, 2006. In August 2018, in connection with the closing of an externalization transaction through which Barings LLC (“Barings” or the “Adviser”) agreed to become our external investment adviser, we entered into an investment advisory agreement (the “Original Advisory Agreement”) and an administration agreement (the “Administration Agreement”) with Barings. In connection with the completion of our acquisition of MVC Capital, Inc., a Delaware corporation, on December 23, 2020 (the “MVC Acquisition”), we entered into an amended and restated investment advisory agreement (the “Amended and Restated Advisory Agreement”) with Barings on December 23, 2020, following approval of the Amended and Restated Advisory Agreement by our stockholders at our December 23, 2020 special meeting of stockholders. The terms of the Amended and Restated Advisory Agreement became effective on January 1, 2021. In connection with the completion of the Sierra Merger (as defined below), on February 25, 2022, we entered into a second amended and restated investment advisory agreement (the “New Barings BDC Advisory Agreement”) with the Adviser. Under the terms of the New Barings BDC Advisory Agreement and the Administration Agreement, Barings serves as our investment adviser and administrator and manages our investment portfolio and performs (or oversees, or arranges for, the performance of) the administrative services necessary for our operation.
An externally-managed BDC generally does not have any employees, and its investment and management functions are provided by an outside investment adviser and administrator under an advisory agreement and administration agreement. Instead of directly compensating employees, we pay Barings for investment management and administrative services pursuant to the terms of an investment advisory agreement and an administration agreement. Under the terms of the New Barings BDC Advisory Agreement, the fees paid to Barings for managing our affairs are determined based upon an objective and fixed formula, as compared with the subjective and variable nature of the costs associated with employing management and employees in an internally-managed BDC structure, which include bonuses that cannot be directly tied to Company performance because of restrictions on incentive compensation under the Investment Company Act of 1940, as amended (the “1940 Act”).
Beginning in August 2018, Barings shifted our investment focus to invest in syndicated senior secured loans, bonds and other fixed income securities. Since that time, Barings has transitioned our portfolio to primarily senior secured private debt investments in well-established middle-market businesses that operate across a wide range of industries. Barings’ existing SEC co-investment exemptive relief under the 1940 Act (the “Exemptive Relief”) permits us and Barings’ affiliated private and SEC-registered funds to co-invest in Barings-originated loans, which allows Barings to efficiently implement its senior secured private debt investment strategy for us.
Barings employs fundamental credit analysis, and targets investments in businesses with relatively low levels of cyclicality and operating risk. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility. Barings has experience managing levered vehicles, both public and private, and will seek to enhance our returns through the use of leverage with a prudent approach that prioritizes capital preservation. Barings believes this strategy and approach offers attractive risk/return with lower volatility given the potential for fewer defaults and greater resilience through market cycles. A significant portion of our investments are expected to be rated below investment grade by rating agencies or, if unrated would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.
We generate revenues in the form of interest income, primarily from our investments in debt securities, loan origination and other fees and dividend income. Fees generated in connection with our debt investments are recognized over the life of the loan using the effective interest method or, in some cases, recognized as earned. Our senior secured, middle-market, private debt investments generally have terms of between five and seven years. Our senior secured, middle-market, first lien private debt investments generally bear interest between the Secured Overnight Financing Rate (“SOFR”) (or the applicable currency rate for investments in foreign currencies) plus 475 basis points and SOFR plus 675 basis points per annum. Our subordinated middle-market, private debt investments generally bear interest between LIBOR (or the applicable currency rate for investments in foreign currencies) plus 700 basis points and LIBOR plus 900 basis points per annum if floating rate, and between 8% and 15% if fixed rate. From time to time, certain of our investments may have a form of interest, referred to as payment-in-kind, or PIK, interest, which is not paid currently but is instead accrued and added to the loan balance and paid at the end of the term.
As of March 31, 2023 and December 31, 2022, the weighted average yield on the principal amount of our outstanding debt investments other than non-accrual debt investments was approximately 10.2% and 9.7%, respectively. The weighted average yield on the principal amount of all of our outstanding debt investments (including non-accrual debt investments) was approximately 9.5% and 9.1% as of March 31, 2023 and December 31, 2022, respectively.
Sierra Income Corporation Acquisition
On February 25, 2022, we completed our acquisition of Sierra Income Corporation, a Maryland corporation (“Sierra”), pursuant to the terms and conditions of that certain Agreement and Plan of Merger (the “Sierra Merger Agreement”), dated as of September 21, 2021, with Sierra, Mercury Acquisition Sub, Inc., a Maryland corporation and our direct wholly owned subsidiary (“Sierra Acquisition Sub”), and Barings. To effect the acquisition, Sierra Acquisition Sub merged with and into Sierra, with Sierra surviving the merger as our wholly owned subsidiary (the “First Sierra Merger”). Immediately thereafter, Sierra merged with and into us, with Barings BDC, Inc. as the surviving company (the “Second Sierra Merger” and, together with the First Sierra Merger, the “Sierra Merger”).
Pursuant to the Sierra Merger Agreement, each share of Sierra common stock, par value $0.001 per share (the “Sierra Common Stock”), issued and outstanding immediately prior to the effective time of the First Sierra Merger (other than shares of Sierra Common Stock issued and outstanding immediately prior to the effective time of the First Sierra Merger that were held by a subsidiary of Sierra or held, directly or indirectly, by us or Sierra Acquisition Sub) was converted into the right to receive (i) an amount in cash from Barings, without interest, equal to $0.9783641, and (ii) 0.44973 shares of our common stock, plus any cash in lieu of fractional shares. As a result of the Sierra Merger, former Sierra stockholders received approximately 46.0 million shares of our common stock for their shares of Sierra Common Stock.
In connection with the Sierra Merger, on February 25, 2022, following the closing of the Sierra Merger, we entered into (1) the New Barings BDC Advisory Agreement, and (2) a credit support agreement (the “Sierra Credit Support Agreement”) with Barings, pursuant to which Barings has agreed to provide credit support to us in the amount of up to $100.0 million relating to the net cumulative realized and unrealized losses on the acquired Sierra investment portfolio over a 10-year period. See “Note 2. Agreements and Related Party Transactions” and “Note. 6 Derivative Instruments” in the Notes to our Unaudited Consolidated Financial Statements included in this Quarterly Report on Form 10-Q for more information.
In addition, in connection with the Sierra Merger, we committed to make open-market purchases of our common stock, pursuant to Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and subject to our compliance with our covenant and regulatory requirements, shares of our common stock in an aggregate amount of up to $30.0 million at then-current market prices at any time the shares of our common stock trade below 90% of our then most recently disclosed net asset value per share during the 12-month period commencing on April 1, 2022.
Relationship with Our Adviser, Barings
Our investment adviser, Barings, a wholly-owned subsidiary of Massachusetts Mutual Life Insurance Company, is a leading global asset management firm and is registered with the SEC as an investment adviser under the Investment Advisers Act of 1940, as amended. Barings’ primary investment capabilities include fixed income, private credit, real estate, equity, and alternative investments. Subject to the overall supervision of the Board, Barings’ Global Private Finance Group (“Barings GPFG”) manages our day-to-day operations, and provides investment advisory and management services to us. Barings GPFG is part of Barings’ $281.6 billion Global Fixed Income Platform (as of March 31, 2023) that invests in liquid, private and structured credit. Barings GPFG manages private funds and separately managed accounts, along with multiple public vehicles.
Among other things, Barings (i) determines the composition of our portfolio, the nature and timing of the changes therein and the manner of implementing such changes; (ii) identifies, evaluates and negotiates the structure of the investments made by us; (iii) executes, closes, services and monitors the investments that we make; (iv) determines the securities and other assets that we will purchase, retain or sell; (v) performs due diligence on prospective portfolio companies and (vi) provides us with such other investment advisory, research and related services as we may, from time to time, reasonably require for the investment of our funds.
Under the terms of the Administration Agreement, Barings (in its capacity as our Administrator) performs (or oversees, or arranges for, the performance of) the administrative services necessary for our operation, including, but not limited to, office facilities, equipment, clerical, bookkeeping and record keeping services at such office facilities and such other services as Barings, subject to review by the Board, will from time to time determine to be necessary or useful to perform its obligations under the Administration Agreement. Barings also, on our behalf and subject to the Board’s oversight, arranges for the services of, and oversees, custodians, depositories, transfer agents, dividend disbursing agents, other stockholder servicing agents, accountants, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Barings is responsible for the financial and other records that we are required to maintain and will prepare all reports and other materials required to be filed with the SEC or any other regulatory authority.
Included in Barings GPFG is Barings North American Private Finance Team (the “U.S. Investment Team”), which consists of 51 investment professionals (as of March 31, 2023) located in three offices in the U.S. The U.S. Investment Team provides a full set of solutions to the North American middle market, including revolvers, first and second lien senior secured loans, unitranche structures, mezzanine debt and equity co-investments. The U.S. Investment Team averages over 20 years of industry experience at the Managing Director and Director level. In addition, Barings believes that it has best-in-class support personnel, including expertise in risk management, legal, accounting, tax, information technology and compliance, among others. We expect to benefit from the support provided by these personnel in our operations.
Stockholder Approval of Reduced Asset Coverage Ratio
On July 24, 2018, our stockholders voted at a special meeting of stockholders (the “2018 Special Meeting”) to approve a proposal to authorize us to be subject to a reduced asset coverage ratio of at least 150% under the 1940 Act. As a result of the stockholder approval at the 2018 Special Meeting, effective July 25, 2018, our applicable asset coverage ratio under the 1940 Act has been decreased to 150% from 200%. As a result, we are permitted under the 1940 Act to incur indebtedness at a level which is more consistent with a portfolio of senior secured debt. As of March 31, 2023, our asset coverage ratio was 180.8%.
Portfolio Composition
The total value of our investment portfolio was $2,556.1 million as of March 31, 2023, as compared to $2,448.9 million as of December 31, 2022. As of March 31, 2023, we had investments in 331 portfolio companies with an aggregate cost of $2,658.5 million. As of December 31, 2022, we had investments in 322 portfolio companies with an aggregate cost of $2,562.4 million. As of both March 31, 2023 and December 31, 2022, none of our portfolio investments represented greater than 10% of the total fair value of our investment portfolio.
As of March 31, 2023 and December 31, 2022, our investment portfolio consisted of the following investments:
($ in thousands)
| March 31, 2023: | Cost | Percentage of Total Portfolio | Fair Value | Percentage of Total Portfolio |
|---|---|---|---|---|
| Senior debt and 1st lien notes | $1,813,687 | 68% | $1,765,238 | 69% |
| Subordinated debt and 2nd lien notes | 318,480 | 12 | 255,089 | 10 |
| Structured products | 96,896 | 4 | 79,343 | 3 |
| Equity shares | 274,704 | 10 | 331,880 | 13 |
| Equity warrants | 178 | — | 1,056 | — |
| Investment in joint ventures / PE fund | 154,539 | 6 | 123,508 | 5 |
| $2,658,484 | 100% | $2,556,114 | 100% | |
| December 31, 2022: | ||||
| Senior debt and 1st lien notes | $1,752,943 | 69% | $1,696,192 | 69% |
| Subordinated debt and 2nd lien notes | 326,639 | 13 | 263,139 | 11 |
| Structured products | 88,805 | 3 | 73,550 | 3 |
| Equity shares | 230,188 | 9 | 284,570 | 12 |
| Equity warrants | 178 | — | 1,057 | — |
| Investment in joint ventures / PE fund | 163,645 | 6 | 130,427 | 5 |
| $2,562,398 | 100% | $2,448,935 | 100% |
Investment Activity
During the three months ended March 31, 2023, we made 11 new investments totaling $65.8 million, made investments in existing portfolio companies totaling $33.9 million and made a $45.0 million equity co-investment alongside certain affiliates in a portfolio company that specializes in providing financing to plaintiff law firms engaged in mass tort and other civil litigation. We had four loans repaid totaling $26.6 million, received $12.7 million of portfolio company principal payments and received $9.1 million of return of capital from our joint ventures. In addition, we sold $1.0 million of loans, recognizing a net realized loss on these transactions of $0.3 million. We received proceeds related to the sale of equity investments totaling $4.3 million and recognized a net realized gain on such sales totaling $1.0 million.
During the three months ended March 31, 2022, we made 22 new investments totaling $229.3 million, purchased $442.2 million of investments as part of the Sierra Merger, made investments in existing portfolio companies totaling $89.3 million and made additional investments in joint venture equity portfolio companies totaling $11.7 million. We had four loans repaid totaling $12.4 million and received $7.5 million of portfolio company principal payments. In addition, we sold $19.2 million of loans, recognizing a net realized gain on these transactions of $0.8 million, and sold $132.3 million of middle-market portfolio company debt investments to one of our joint ventures and realized a loss on these transactions of $0.2 million. Lastly, we received proceeds related to the sale of equity investments totaling $1.6 million and recognized a net realized loss on such sales totaling $0.7 million.
Total portfolio investment activity for the three months ended March 31, 2023 and 2022 was as follows:
| Three Months Ended March 31, 2023: ($ in thousands) | Senior Debt and 1st Lien Notes | Subordinated Debt and 2nd Lien Notes | Structured Products | Equity Shares | Equity Warrants | Investments in Joint Ventures / PE Fund | Total |
|---|---|---|---|---|---|---|---|
| Fair value, beginning of period | $1,696,192 | $263,139 | $73,550 | $284,570 | $1,057 | $130,427 | $2,448,935 |
| New investments | 86,805 | 769 | 9,382 | 47,763 | — | — | 144,719 |
| Proceeds from sales of investments/return of capital | (979) | — | (902) | (4,297) | — | (9,106) | (15,284) |
| Loan origination fees received | (2,397) | (23) | — | — | — | — | (2,420) |
| Principal repayments received | (26,475) | (11,445) | (394) | — | — | — | (38,314) |
| Payment-in-kind interest/dividend | 1,974 | 2,319 | — | — | — | — | 4,293 |
| Accretion of loan premium/discount | 243 | 55 | 5 | — | — | — | 303 |
| Accretion of deferred loan origination revenue | 1,856 | 161 | — | — | — | — | 2,017 |
| Realized gain (loss) | (282) | 4 | — | 1,049 | — | — | 771 |
| Unrealized appreciation (depreciation) | 8,301 | 110 | (2,298) | 2,795 | (1) | 2,187 | 11,094 |
| Fair value, end of period | $1,765,238 | $255,089 | $79,343 | $331,880 | $1,056 | $123,508 | $2,556,114 |
| Three Months Ended March 31, 2022: ($ in thousands) | Senior Debt and 1st Lien Notes | Subordinated Debt and 2nd Lien Notes | Structured Products | Equity Shares | Equity Warrants | Investments in Joint Ventures / PE Fund | Total |
|---|---|---|---|---|---|---|---|
| Fair value, beginning of period | $1,221,598 | $240,037 | $40,271 | $154,477 | $1,107 | $143,104 | $1,800,594 |
| New investments | 268,202 | 30,065 | 1,060 | 19,200 | — | 11,696 | 330,223 |
| Investments acquired in Sierra merger | 235,770 | 66,662 | 46,666 | 7,065 | 72 | 85,963 | 442,198 |
| Proceeds from sales of investments | (151,575) | — | — | (1,388) | (249) | — | (153,212) |
| Loan origination fees received | (5,350) | 36 | — | — | — | — | (5,314) |
| Principal repayments received | (8,114) | (11,020) | (730) | — | — | — | (19,864) |
| Payment-in-kind interest/dividend | 1,050 | 6,984 | — | — | — | — | 8,034 |
| Accretion of loan premium/discount | 301 | 33 | 5 | — | — | — | 339 |
| Accretion of deferred loan origination revenue | 1,461 | 62 | — | — | — | — | 1,523 |
| Realized gain (loss) | 579 | 8 | — | 24 | (760) | — | (149) |
| Unrealized appreciation (depreciation) | (8,176) | (15,224) | (5,258) | 40,088 | (14) | (12,363) | (947) |
| Fair value, end of period | $1,555,746 | $317,643 | $82,014 | $219,466 | $156 | $228,400 | $2,403,425 |
Non-Accrual Assets
Generally, when interest and/or principal payments on a loan become past due, or if we otherwise do not expect the borrower to be able to service its debt and other obligations, we will place the loan on non-accrual status and will generally cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to a restructuring such that the interest income is deemed to be collectible. As of March 31, 2023, we had nine portfolio companies with investments on non-accrual, the fair value of which was $28.5 million, which comprised 1.1% of the total fair value of our portfolio, and the cost of which was $102.3 million, which comprised 3.8% of the total cost of our portfolio. As of December 31, 2022, we had seven portfolio companies with investments on non-accrual, the fair value of which was $24.3 million, which comprised 1.0% of the total fair value of our portfolio, and the cost of which was $98.8 million, which comprised 3.9% of the total cost of our portfolio.
A summary of our non-accrual assets as of March 31, 2023 is provided below:
1888 Industrial Services, LLC
In connection with the Sierra Merger, we purchased our debt and equity investments in 1888 Industrial Services, LLC, or 1888. The 1888 debt investments are on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our debt investments in 1888 for financial reporting purposes. As of March 31, 2023, the cost of our debt investments in 1888 was $1.9 million and the fair value of such investments was $1.1 million.
Black Angus Steakhouse, LLC
In connection with the Sierra Merger, we purchased our debt and equity investments in Black Angus Steakhouse, LLC, or Black Angus. The Black Angus PIK term loan is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our PIK term loan in Black Angus for financial reporting purposes. As of March 31, 2023, the cost of the PIK term loan in Black Angus was $9.6 million and the fair value of such investment was $8.8 million.
Core Scientific, Inc.
During the quarter ended December 31, 2022, we placed our debt investment in Core Scientific, Inc., or Core Scientific, on non-accrual status effective with the monthly payment due October 31, 2022. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Core Scientific for financial reporting purposes. As of March 31, 2023, the cost of our debt investment in Core Scientific was $29.6 million and the fair value of such investment was $15.0 million.
Custom Alloy Corporation
In connection with the MVC Acquisition, we purchased our debt investment in Custom Alloy Corporation, or Custom Alloy. During the quarter ended December 31, 2021, we placed our debt investment in Custom Alloy on non-accrual status. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Custom Alloy for financial reporting purposes. As of March 31, 2023, the cost of our debt investment in Custom Alloy was $46.4 million and the fair value of such investment was $0.9 million.
Holland Acquisition Corp.
In connection with the Sierra Merger, we purchased our debt investment in Holland Acquisition Corp., or Holland. Holland is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Holland for financial reporting purposes. As of March 31, 2023, both the cost and fair value of our debt investment in Holland was nil.
Isagenix International, LLC
In connection with the Sierra Merger, we purchased our debt investment in Isagenix International, LLC, or Isagenix. During the quarter ended September 30, 2022, we placed our debt investment in Isagenix on non-accrual status. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Isagenix for financial reporting purposes. As of March 31, 2023, the cost of our debt investment in Isagenix was $1.2 million and the fair value of such investment was $0.5 million.
Legal Solutions Holdings
In connection with the MVC Acquisition, we purchased our debt investment in Legal Solutions Holdings, or Legal Solutions. During the quarter ended September 30, 2021, we placed our debt investment in Legal Solutions on non-accrual status. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Legal Solutions for financial reporting purposes. As of March 31, 2023, the cost of our debt investment in Legal Solutions was $10.1 million and the fair value of such investment was $39.4 thousand.
Serta Simmons Bedding LLC
During the quarter ended March 31, 2023, we placed our Super Priority Second Out, or Second Out, debt investment in Serta Simmons Bedding LLC, or Serta Simmons, on non-accrual status effective with the quarterly payment due on March 31, 2023. As a result, under U.S. GAAP, we will not recognize interest income on our Second Out debt investment in Serta Simmons for financial reporting purposes. As of March 31, 2023, the cost of our Second Out debt investment in Serta Simmons was $3.4 million and the fair value of such investments was $2.0 million.
Wawona Delaware Holdings, LLC
In connection with the Sierra Merger, we purchased our debt investment in Wawona Delaware Holdings, LLC, or Wawona. During the quarter ended March 31, 2023, we placed our debt investment in Wawona on non-accrual status. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Wawona for financial reporting purposes. As of March 31, 2023, the cost of our debt investment in Wawona was $41.0 thousand and the fair value of such investment was $30.4 thousand.
Results of Operations
Comparison of the three months ended March 31, 2023 and March 31, 2022
Operating results for the three months ended March 31, 2023 and 2022 were as follows:
($ in thousands)
| Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | |
|---|---|---|
| Total investment income | $67,204 | $43,757 |
| Total operating expenses | 39,509 | 24,742 |
| Net investment income before taxes | 27,695 | 19,015 |
| Income taxes, including excise tax provision | 195 | 6 |
| Net investment income after taxes | 27,500 | 19,009 |
| Net realized gains (losses) | (9,746) | (1,442) |
| Net unrealized appreciation (depreciation) | 21,970 | 3,465 |
| Benefit from (provision for) taxes | (73) | — |
| Net increase in net assets resulting from operations | $39,651 | $21,032 |
Net increases or decreases in net assets resulting from operations vary substantially from period to period due to various factors, including recognition of realized gains and losses and unrealized appreciation and depreciation. As a result, quarterly comparisons of net increases or decreases in net assets resulting from operations may not be meaningful.
Investment Income
($ in thousands)
| Investment income: | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 |
|---|---|---|
| Total interest income | $51,890 | $32,069 |
| Total dividend income | 7,874 | 7,693 |
| Total fee and other income | 3,300 | 1,197 |
| Total payment-in-kind interest income | 3,942 | 2,798 |
| Interest income from cash | 198 | — |
| Total investment income | $67,204 | $43,757 |
The change in total investment income for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to an increase in the weighted average yield on the portfolio from higher base rates, an increase in the average size of our portfolio, increased dividends from portfolio companies and joint venture investments and increased payment-in-kind (“PIK”) interest income. The weighted average yield on the principal amount of our outstanding debt investments, other than non-accrual debt investments was 10.2% as of March 31, 2023, as compared to 7.3% as of March 31, 2022. The amount of our outstanding debt investments was $2,353.1 million as of March 31, 2023, as compared to $2,134.2 million as of March 31, 2022. The increase in the average size of our portfolio was largely due to the increased middle-market investment opportunities and special situation investment opportunities. For three months ended March 31,
2022, the portfolio included the investments acquired as part of the Sierra Merger; however, as the Sierra Merger did not close until late in the first quarter of 2022, we did not receive a full quarter of investment income from the acquired Sierra portfolio for the three months ended March 31, 2022. For the three months ended March 31, 2023, dividends from portfolio companies and joint venture investments were $7.9 million, as compared to $7.7 million for the three months ended March 31, 2022. For the three months ended March 31, 2023, acceleration of unamortized OID income and unamortized loan origination fees totaled $0.3 million as compared to $0.2 million for the three months ended March 31, 2022. For the three months ended March 31, 2023, PIK interest income was $3.9 million, as compared to $2.8 million for the three months ended March 31, 2022.
Operating Expenses
($ in thousands)
| Operating expenses: | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 |
|---|---|---|
| Interest and other financing fees | $19,316 | $11,661 |
| Base management fees | 7,853 | 5,872 |
| Incentive management fees | 9,604 | 4,754 |
| General and administrative expenses | 2,736 | 2,455 |
| Total operating expenses | $39,509 | $24,742 |
Interest and Other Financing Fees
Interest and other financing fees during both the three months ended March 31, 2023 and March 31, 2022 were attributable to borrowings under the February 2019 Credit Facility, the August 2025 Notes, the November Notes, the February Notes and the November 2026 Notes (each as defined below under “Liquidity and Capital Resources”). The increase in interest and other financing fees for the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, was primarily attributable to increase in the weighted average interest rate on the February 2019 Credit Facility. The weighted average interest on the February 2019 Credit Facility was 6.3% as of March 31, 2023, as compared to 2.2% as of March 31, 2022.
Base Management Fees
Under the terms of the New Barings BDC Advisory Agreement, we pay Barings a base management fee (the “Base Management Fee”), quarterly in arrears on a calendar quarter basis. The Base Management Fee is calculated based on the average value of our gross assets, excluding cash and cash equivalents, at the end of the two most recently completed calendar quarters prior to the quarter for which such fees are being calculated. Base Management Fees for any partial month or quarter are appropriately pro-rated. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the terms of the New Barings BDC Advisory Agreement and the fee arrangements thereunder. For the three months ended March 31, 2023, the amount of Base Management Fee incurred was approximately $7.9 million. For the three months ended March 31, 2022, the amount of Base Management Fee incurred was approximately $5.9 million. The increase in the Base Management Fee for the three months ended March 31, 2023 versus the corresponding 2022 period is primarily related to the average value of gross assets increasing from $1,879.0 million as of the end of the two most recently completed calendar quarters prior to March 31, 2022 to $2,512.9 million as of the end of the two most recently completed calendar quarters prior to March 31, 2023. For both the three months ended March 31, 2023 and 2022, the Base Management Fee rate was 1.250%.
Incentive Fee
Under the New Barings BDC Advisory Agreement, we pay Barings an incentive fee. A portion of the incentive fee is based on our income and a portion is based on our capital gains. The income-based fee will be determined and paid quarterly in arrears based on the amount by which (x) the aggregate pre-incentive fee net investment income in respect of the current calendar quarter and the eleven preceding calendar quarters beginning with the calendar quarter that commences on or after January 1, 2021, as the case may be (or the appropriate portion thereof in the case of any of our first eleven calendar quarters that commences on or after January 1, 2021) exceeds (y) the hurdle amount as calculated for the same period. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the terms of the New Barings BDC Advisory Agreement and the fee arrangements thereunder. For the three months ended March 31, 2023, the amount of income-based fee incurred was $9.6 million, as compared to $4.8 million for the three months ended March 31, 2022. The increase in the incentive fee for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, relates predominately to an increase in pre-incentive fee net investment income. The amount of pre-incentive fee net investment income was $37.3 million as of March 31, 2023, as compared to $23.8 million as of March 31, 2022.
General and Administrative Expenses
We entered into the Administration Agreement with Barings in August 2018. Under the terms of the Administration Agreement, Barings performs (or oversees, or arranges for, the performance of) the administrative services necessary for our operations. We reimburse Barings for the costs and expenses incurred by it in performing its obligations and providing personnel and facilities under the Administration Agreement in an amount to be negotiated and mutually agreed to by us and Barings quarterly in arrears; provided that the agreed-upon quarterly expense amount will not exceed the amount of expenses that would otherwise be reimbursable by us under the Administration Agreement for the applicable quarterly period, and Barings will not be entitled to the recoupment of any amounts in excess of the agreed-upon quarterly expense amount. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the Administration Agreement. For the three months ended March 31, 2023, the amount of administration expense incurred and invoiced by Barings for expenses was approximately $0.7 million. For the three months ended March 31, 2022, the amount of administration expense incurred and invoiced by Barings for expenses was approximately $1.0 million. In addition to expenses incurred under the Administration Agreement, general and administrative expenses include fees payable to the members of our board of directors (the “Board”) for their service on the Board, D&O insurance costs, as well as legal and accounting expenses.
Net Realized Gains (Losses)
Net realized gains (losses) during the three months ended March 31, 2023 and 2022 were as follows:
($ in thousands)
| Net realized gain (losses): | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 |
|---|---|---|
| Non-Control / Non-Affiliate investments | $771 | $(250) |
| Affiliate investments | — | 101 |
| Net realized gains (losses) on investments | 771 | (149) |
| Foreign currency transactions | (10,517) | (1,293) |
| Net realized gains (losses) | $(9,746) | $(1,442) |
During the three months ended March 31, 2023, we recognized net realized losses totaling $9.7 million, which consisted primarily of a net loss on foreign currency transactions of $10.5 million, partially offset by a net gain on our investment portfolio of $0.8 million. During the three months ended March 31, 2022, we recognized net realized losses totaling $1.4 million, which consisted primarily of a net loss on foreign currency transactions of $1.3 million.
Net Unrealized Appreciation (Depreciation)
Net unrealized appreciation (depreciation) during the three months ended March 31, 2023 and 2022 was as follows:
($ in thousands)
| Net unrealized appreciation (depreciation): | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 |
|---|---|---|
| Non-Control / Non-Affiliate investments | $7,437 | $(28,587) |
| Affiliate investments | 10,841 | 12,996 |
| Control investments | (7,269) | 14,644 |
| Net unrealized appreciation (depreciation) on investments | 11,009 | (947) |
| Credit support agreements | 5,586 | (400) |
| Foreign currency transactions | 5,375 | 4,812 |
| Net unrealized appreciation (depreciation) | $21,970 | $3,465 |
During the three months ended March 31, 2023, we recorded net unrealized appreciation totaling $22.0 million, consisting of net unrealized appreciation on our current portfolio of $11.8 million, unrealized appreciation of $0.9 million on the MVC credit support agreement with Barings, unrealized appreciation of $4.7 million on the Sierra credit support agreement with Barings, net unrealized appreciation related to foreign currency transactions of $5.4 million, net of unrealized depreciation reclassification adjustments of $0.7 million related to the net realized gains on the sales / repayments of certain investments and $0.1 million of deferred taxes. The net unrealized appreciation on our current portfolio of $11.8 million was driven primarily by broad market moves for investments of $4.0 million, credit or fundamental performance of investments of $0.9 million and the impact of foreign currency exchange rates on investments of $6.9 million.
During the three months ended March 31, 2022, we recorded net unrealized appreciation totaling $3.5 million, consisting of net unrealized appreciation on our current portfolio of $0.1 million and net unrealized appreciation related to foreign currency transactions of $4.8 million, net of unrealized depreciation of $0.4 million on the MVC credit support agreement with Barings and net unrealized depreciation reclassification adjustments of $1.0 million related to the realized gains on the sales/ repayments of certain investments. The net unrealized appreciation on our current portfolio of $0.1 million was driven primarily by credit or fundamental performance of investments of $27.8 million, partially offset by the impact of foreign currency exchange rates on investments of $4.7 million and broad market moves for investments of $23.1 million.
Liquidity and Capital Resources
We believe that our current cash and foreign currencies on hand, our available borrowing capacity under the February 2019 Credit Facility and our anticipated cash flows from operations will be adequate to meet our cash needs for our daily operations for at least the next twelve months. This “Liquidity and Capital Resources” section should be read in conjunction with the notes to our Unaudited Consolidated Financial Statements.
Cash Flows
For the three months ended March 31, 2023, we experienced a net decrease in cash in the amount of $84.0 million. During that period, our operating activities used $92.0 million in cash, consisting primarily of purchases of portfolio investments of $179.6 million partially offset by proceeds from sales or repayments of portfolio investments totaling $69.5 million. In addition, our financing activities provided net cash of $8.0 million, consisting of net borrowings under the February 2019 Credit Facility (as defined below under “Financing Transactions”) of $35.0 million, partially offset by dividends paid in the amount of $27.0 million. As of March 31, 2023, we had $55.4 million of cash and foreign currencies on hand.
For the three months ended March 31, 2022, we experienced a net increase in cash in the amount of $70.2 million. During that period, our operating activities used $18.8 million in cash, consisting primarily of purchases of portfolio investments of $335.5 million, partially offset by net cash acquired from the acquisition of Sierra of $101.9 million and proceeds from sales or repayments of portfolio investments totaling $210.5 million. In addition, our financing activities provided net cash of $89.0 million, consisting of net borrowings under the February 2019 Credit Facility (as defined below under “Financing Transactions”) of $107.7 million, partially offset by dividends paid in the amount of $15.0 million and share repurchases of $2.1 million. As of March 31, 2022, we had $154.4 million of cash and foreign currencies on hand.
Financing Transactions
February 2019 Credit Facility
On February 21, 2019, we entered into a senior secured credit facility with ING Capital LLC (“ING”), as administrative agent, and the lenders party thereto (as amended, restated and otherwise modified from time to time, the “February 2019 Credit Facility”). The initial commitments under the February 2019 Credit Facility total $800.0 million. Effective on November 4, 2021, we increased aggregate commitments under the February 2019 Credit Facility to $875.0 million from $800.0 million pursuant to the accordion feature under the February 2019 Credit Facility, which allows for an increase in the total commitments to an aggregate of $1.2 billion subject to certain conditions and the satisfaction of specified financial covenants (the “February 2022 Amendment”). Effective on February 25, 2022, we increased aggregate commitments under the February 2019 Credit Facility to $965.0 million from $875.0 million pursuant to the accordion feature under the February 2019 Credit Facility, and the allowance for an increase in the total commitments increased to $1.5 billion from $1.2 billion subject to certain conditions and the satisfaction of specified financial covenants. Effective on April 1, 2022, we increased the aggregate commitments under the February 2019 Credit Facility to $1.1 billion from $965.0 million pursuant to the accordion feature under the February 2019 Credit Facility, which allows for an increase in the total commitments to an aggregate of $1.5 billion subject to certain conditions and the satisfaction of specified financial covenants. We can borrow foreign currencies directly under the February 2019 Credit Facility (the “April 2022 Amendment”). The February 2019 Credit Facility, which is structured as a revolving credit facility, is secured primarily by a material portion of our assets and guaranteed by certain of our subsidiaries. Following the termination on June 30, 2020 of Barings BDC Senior Funding I, LLC’s (“BSF”) credit facility entered into in August 2018 with Bank of America, N.A. (the “August 2018 Credit Facility”), BSF became a subsidiary guarantor and its assets secure the February 2019 Credit Facility. The revolving period of the February 2019 Credit Facility ends on February 21, 2024, followed by a one-year repayment period with a maturity date of February 21, 2025.
Borrowings denominated in U.S. Dollars under the February 2019 Credit Facility bear interest, subject to our election, on a per annum basis equal to (i) the alternate base rate plus 1.25% (or 1.00% for so long as we maintain an investment grade credit rating) or (ii) the term Secured Overnight Financing Rate (“SOFR”) plus 2.25% (or 2.00% for so long as we maintain an investment grade credit rating) plus a credit spread adjustment of 0.10% for borrowings with an interest period of one month, 0.15% for borrowings with an interest period of three months or 0.25% for borrowings with an interest period of six months.
For borrowings denominated in certain foreign currencies other than Australian dollars, the applicable currency rate for the foreign currency as defined in the credit agreement plus 2.00% (or 2.25% if we no longer maintain an investment grade credit rating) or for borrowings denominated in Australian dollars, the applicable Australian dollars Screen Rate, plus 2.20% (or 2.45% if we no longer maintain an investment grade credit rating). The alternate base rate is equal to the greatest of (i) the prime rate, (ii) the federal funds rate plus 0.5%, (iii) the Overnight Bank Funding Rate plus 0.5%, (iv) one-month term SOFR plus 1.0% plus a credit spread adjustment of 0.10% and (v) 1.0%.
In addition, we pay a commitment fee of (i) 0.5% per annum on undrawn amounts if the unused portion of the February 2019 Credit Facility is greater than two-thirds of total commitments or (ii) 0.375% per annum on undrawn amounts if the unused portion of the February 2019 Credit Facility is equal to or less than two-thirds of total commitments. In connection with entering into the February 2019 Credit Facility, we incurred financing fees of approximately $6.4 million, which will be amortized over the life of the February 2019 Credit Facility. In connection with the February 2022 Amendment and the April 2022 Amendment, we incurred financing fees of approximately $1.7 million, which will be amortized over the remaining life of the February 2019 Credit Facility.
As of March 31, 2023, we were in compliance with all covenants under the February 2019 Credit Facility and had U.S. dollar borrowings of $532.5 million outstanding under the February 2019 Credit Facility with an interest rate of 6.798% (one month SOFR of 4.698%), borrowings denominated in Swedish krona of 12.8kr million ($1.2 million U.S. dollars) with an interest rate of 5.000% (one month STIBOR of 3.000%), borrowings denominated in British pounds sterling of £68.6 million ($84.8 million U.S. dollars) with an interest rate of 5.960% (one month SONIA of 3.960%) and borrowings denominated in Euros of €138.6 million ($150.6 million U.S. dollars) with an interest rate of 4.625% (one month EURIBOR of 2.625%). The borrowings denominated in foreign currencies were translated into U.S. dollars based on the spot rate at the relevant balance sheet date. The impact resulting from changes in foreign exchange rates on the February 2019 Credit Facility borrowings is included in “Net unrealized appreciation (depreciation) - foreign currency transactions” in our Unaudited Consolidated Statements of Operations.
The fair values of the borrowings outstanding under the February 2019 Credit Facility are based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model. As of March 31, 2023, the total fair value of the borrowings outstanding under the February 2019 Credit Facility was $769.1 million. See Note 5 to our Unaudited Consolidated Financial Statements for additional information regarding the February 2019 Credit Facility.
August 2025 Notes
On August 3, 2020, we entered into a Note Purchase Agreement (the “August 2020 NPA”) with Massachusetts Mutual Life Insurance Company governing the issuance of (1) $50.0 million in aggregate principal amount of Series A senior unsecured notes due August 2025 (the “Series A Notes due 2025”) with a fixed interest rate of 4.66% per year, and (2) up to $50.0 million in aggregate principal amount of additional senior unsecured notes due August 2025 with a fixed interest rate per year to be determined (the “Additional Notes” and, collectively with the Series A Notes due 2025, the “August 2025 Notes”), in each case, to qualified institutional investors in a private placement. An aggregate principal amount of $25.0 million of the Series A Notes due 2025 was issued on September 24, 2020 and an aggregate principal amount of $25.0 million of the Series A Notes due 2025 was issued on September 29, 2020, both of which will mature on August 4, 2025 unless redeemed, purchased or prepaid prior to such date by us in accordance with their terms. Interest on the August 2025 Notes is due semiannually in March and September, beginning in March 2021. In addition, we are obligated to offer to repay the August 2025 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the August 2020 NPA, we may redeem the August 2025 Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if redeemed on or before November 3, 2024, a make-whole premium. The August 2025 Notes are guaranteed by certain of our subsidiaries, and are our general unsecured obligations that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by us.
The Company’s permitted issuance period for the Additional Notes under the August 2020 NPA expired on February 3, 2022, prior to which date the Company issued no Additional Notes.
The August 2020 NPA contains certain representations and warranties, and various covenants and reporting requirements customary for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants such as information reporting, maintenance of our status as a BDC within the meaning of the 1940 Act, certain restrictions with respect to transactions with affiliates, fundamental changes, changes of line of business, permitted liens, investments and restricted payments, minimum shareholders’ equity, maximum net debt to equity ratio and minimum asset coverage ratio. The August 2020 NPA also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under our other indebtedness or that of our subsidiary guarantors, certain judgements and orders, and certain events of bankruptcy. Upon the occurrence of an event of default, the holders of at least 66-2/3% in principal amount of the August 2025 Notes at the time outstanding may declare all August 2025 Notes then outstanding to be immediately due and payable. As of March 31, 2023, we were in compliance with all covenants under the August 2020 NPA.
The August 2025 Notes were offered in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The August 2025 Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.
As of March 31, 2023, the fair value of the outstanding August 2025 Notes was $46.6 million. The fair value determination of the August 2025 Notes was based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.
November Notes
On November 4, 2020, we entered into a Note Purchase Agreement (the “November 2020 NPA”) governing the issuance of (1) $62.5 million in aggregate principal amount of Series B senior unsecured notes due November 2025 (the “Series B Notes”) with a fixed interest rate of 4.25% per year and (2) $112.5 million in aggregate principal amount of Series C senior unsecured notes due November 2027 (the “Series C Notes,” and, collectively with the Series B Notes, the “November Notes”) with a fixed interest rate of 4.75% per year, in each case, to qualified institutional investors in a private placement. Each stated interest rate is subject to a step up of (x) 0.75% per year, to the extent the applicable November Notes do not satisfy certain investment grade conditions and/or (y) 1.50% per year, to the extent the ratio of our secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter end. The November Notes were delivered and paid for on November 5, 2020.
The Series B Notes will mature on November 4, 2025, and the Series C Notes will mature on November 4, 2027 unless redeemed, purchased or prepaid prior to such date by us in accordance with their terms. Interest on the November Notes is due semiannually in May and November, beginning in May 2021. In addition, we are obligated to offer to repay the November Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the November 2020 NPA, we may redeem the Series B Notes and the Series C Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if redeemed on or before May 4, 2025, with respect to the Series B Notes, or on or before May 4, 2027, with respect to the Series C Notes, a make-whole premium. The November Notes are guaranteed by certain of our subsidiaries, and are our general unsecured obligations that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by us.
The November 2020 NPA contains certain representations and warranties, and various covenants and reporting requirements customary for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants such as information reporting, maintenance of our status as a BDC within the meaning of the 1940 Act, certain restrictions with respect to transactions with affiliates, fundamental changes, changes of line of business, permitted liens, investments and restricted payments, minimum shareholders’ equity, maximum net debt to equity ratio and minimum asset coverage ratio. The November 2020 NPA also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under our other indebtedness or that of our subsidiary guarantors, certain judgements and orders, and certain events of bankruptcy. Upon the occurrence of an event of default, the holders of at least 66-2/3% in principal amount of the November Notes at the time outstanding may declare all November Notes then outstanding to be immediately due and payable. As of March 31, 2023, we were in compliance with all covenants under the November 2020 NPA.
The November Notes were offered in reliance on Section 4(a)(2) of the Securities Act. The November Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.
As of March 31, 2023, the fair value of the outstanding Series B Notes and the Series C Notes was $56.8 million and $98.3 million, respectively. The fair value determinations of the Series B Notes and Series C Notes were based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.
February Notes
On February 25, 2021, we entered into a Note Purchase Agreement (the “February 2021 NPA”) governing the issuance of (1) $80.0 million in aggregate principal amount of Series D senior unsecured notes due February 26, 2026 (the “Series D
Notes”) with a fixed interest rate of 3.41% per year and (2) $70.0 million in aggregate principal amount of Series E senior unsecured notes due February 26, 2028 (the “Series E Notes” and, collectively with the Series D Notes, the “February Notes”) with a fixed interest rate of 4.06% per year, in each case, to qualified institutional investors in a private placement. Each stated interest rate is subject to a step up of (x) 0.75% per year, to the extent the applicable February Notes do not satisfy certain investment grade rating conditions and/or (y) 1.50% per year, to the extent the ratio of our secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter end. The February Notes were delivered and paid for on February 26, 2021.
The Series D Notes will mature on February 26, 2026, and the Series E Notes will mature on February 26, 2028 unless redeemed, purchased or prepaid prior to such date by us in accordance with the terms of the February 2021 NPA. Interest on the February Notes is due semiannually in February and August of each year, beginning in August 2021. In addition, we are obligated to offer to repay the February Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the February 2021 NPA, we may redeem the Series D Notes and the Series E Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if redeemed on or before August 26, 2025, with respect to the Series D Notes, or on or before August 26, 2027, with respect to the Series E Notes, a make-whole premium. The February Notes are guaranteed by certain of our subsidiaries, and are our general unsecured obligations that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by us.
The February 2021 NPA contains certain representations and warranties, and various covenants and reporting requirements customary for senior unsecured notes issued in a private placement, including, without limitation, information reporting, maintenance of our status as a BDC within the meaning of the 1940 Act, and certain restrictions with respect to transactions with affiliates, fundamental changes, changes of line of business, permitted liens, investments and restricted payments. In addition, the February 2021 NPA contains the following financial covenants: (a) maintaining a minimum obligors’ net worth, measured as of each fiscal quarter end; (b) not permitting our asset coverage ratio, as of the date of the incurrence of any debt for borrowed money or the making of any cash dividend to shareholders, to be less than the statutory minimum then applicable to us under the 1940 Act; and (c) not permitting our net debt to equity ratio to exceed 2.0x, measured as of each fiscal quarter end.
The February 2021 NPA also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under other indebtedness or that of our subsidiary guarantors, certain judgements and orders, and certain events of bankruptcy. Upon the occurrence of certain events of default, the holders of at least 66-2/3% in principal amount of the February Notes at the time outstanding may declare all February Notes then outstanding to be immediately due and payable. As of March 31, 2023, we were in compliance with all covenants under the February 2021 NPA.
The February Notes were offered in reliance on Section 4(a)(2) of the Securities Act. The February Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.
As of March 31, 2023, the fair value of the outstanding Series D Notes and the Series E Notes was $70.9 million and $59.1 million, respectively. The fair value determinations of the Series D Notes and Series E Notes were based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.
November 2026 Notes
On November 23, 2021, we entered into an Indenture (the “Base Indenture”) and a Supplemental Indenture (the “First Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) with U.S. Bank National Association (the “Trustee”). The First Supplemental Indenture relates to our issuance of $350.0 million aggregate principal amount of its 3.300% notes due 2026 (the “November 2026 Notes”).
The November 2026 Notes will mature on November 23, 2026 and may be redeemed in whole or in part at our option at any time or from time to time at the redemption prices set forth in the Indenture. The November 2026 Notes bear interest at a rate of 3.300% per year payable semi-annually on May 23 and November 23 of each year, commencing on May 23, 2022. The November 2026 Notes are our general unsecured obligations that rank senior in right of payment to all of our existing and future indebtedness that is expressly subordinated in right of payment to the November 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by us, rank effectively junior to any of our secured indebtedness (including unsecured indebtedness that we later secure) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by our subsidiaries, financing vehicles or similar facilities.
The Indenture contains certain covenants, including covenants requiring us to comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Sections 61(a)(1) and (2) of the 1940 Act, whether or not we are subject to those requirements, and to provide financial information to the holders of the November 2026 Notes and the Trustee if we are no longer subject to the reporting requirements under the Exchange Act. These covenants are subject to important limitations and exceptions that are described in the Indenture.
In addition, on the occurrence of a “change of control repurchase event,” as defined in the Indenture, we will generally be required to make an offer to purchase the outstanding November 2026 Notes at a price equal to 100% of the principal amount of such November 2026 Notes plus accrued and unpaid interest to the repurchase date.
The November 2026 Notes were offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. Concurrent with the closing of November 2026 Notes offering, we entered into a registration rights agreement for the benefit of the purchasers of the November 2026 Notes. Pursuant to the terms of this registration rights agreement, we filed a registration statement on Form N-14 with the SEC, which was subsequently declared effective, to permit electing holders of the November 2026 Notes to exchange all of their outstanding restricted November 2026 Notes for an equal aggregate principal amount of new November 2026 Notes (the “Exchange Notes”). The Exchange Notes have terms substantially identical to the terms of the November 2026 Notes, except that the Exchange Notes are registered under the Securities Act, and certain transfer restrictions, registration rights, and additional interest provisions relating to the November 2026 Notes do not apply to the Exchange Notes.
As of March 31, 2023, the fair value of the outstanding November 2026 Notes was $296.5 million. The fair value determinations of the November 2026 Notes were based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.
Share Repurchase Program
In connection with the closing of the MVC Acquisition on December 23, 2020, we committed to make open-market purchases of shares of our common stock in an aggregate amount of up to $15.0 million at then-current market prices at any time shares trade below 90% of our then most recently disclosed NAV per share. Any repurchases pursuant to the authorized program occurred during the 12-month period that commenced upon the filing of our quarterly report on Form 10-Q for the quarter ended March 31, 2021, which occurred on May 6, 2021, and were made in accordance with applicable legal, contractual and regulatory requirements. The MVC-related repurchase program terminated on May 6, 2022. Prior to its termination, we repurchased a total of 207,677 shares of common stock in the open market under the MVC repurchase program at an average price of $10.14 per share, including broker commissions.
In connection with the completion of the acquisition of Sierra, we committed to make open-market purchases of shares of our common stock in an aggregate amount of up to $30.0 million at then-current market prices at any time shares trade below 90% of our then most recently disclosed NAV per share. Any repurchases pursuant to the authorized program occurred during the 12-month period commencing on April 1, 2022 and were made in accordance with a Rule 10b5-1 purchase plan that qualifies for the safe harbors provided by Rules 10b5-1 and 10b-18 under the Exchange Act, as well as subject to compliance with our covenant and regulatory requirements. During the year ended December 31, 2022, we repurchased the maximum amount of $30.0 million of common stock authorized under the Sierra share repurchase program. In total under the Sierra share repurchase program, we repurchased a total of 3,179,168 shares of common stock in the open market under the authorized program at an average price of $9.44 per share, including broker commissions.
On February 23, 2023, our Board authorized a new 12-month share repurchase program. Under the program, we may repurchase, during the 12-month period commencing on March 1, 2023, up to $30.0 million in the aggregate of our outstanding common stock in the open market at prices below the then-current NAV per share. The timing, manner, price and amount of any share repurchases will be determined by us, at our discretion, based upon the evaluation of economic and market conditions, our stock price, applicable legal, contractual and regulatory requirements and other factors. The program is expected to be in effect until March 1, 2024, unless extended or until the aggregate repurchase amount that has been approved by our Board has been expended. The program does not require us to repurchase any specific number of shares, and we cannot assure stockholders that any shares will be repurchased under the program. The program may be suspended, extended, modified or discontinued at any time. During the three months ended March 31, 2023, we did not repurchase any shares.
Distributions to Stockholders
We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of dividends on behalf of our stockholders, unless a stockholder elects to receive cash. As a result, when we declare a dividend, stockholders who have not opted out of the DRIP will have their dividends automatically reinvested in shares of our common stock, rather than receiving cash dividends.
We have elected to be treated as a RIC under the Code, and intend to make the required distributions to our stockholders as specified therein. In order to maintain our tax treatment as a RIC and to obtain RIC tax benefits, we must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then we are generally required to pay income taxes only on the portion of our taxable income and gains we do not distribute (actually or constructively) and certain built-in gains. We have historically met our minimum distribution requirements and continually monitor our distribution requirements with the goal of ensuring compliance with the Code. We can offer no assurance that we will achieve results that will permit the payment of any level of cash distributions and our ability to make distributions will be limited by the asset coverage requirement and related provisions under the 1940 Act and contained in any applicable indenture or financing agreement and related supplements. In addition, in order to satisfy the annual distribution requirement applicable to RICs, we may declare a significant portion of our dividends in shares of our common stock instead of in cash. As long as a portion of such dividend is paid in cash (which portion may be as low as 20% of such dividend under published guidance from the Internal Revenue Service) and certain requirements are met, the entire distribution will be treated as a dividend for U.S. federal income tax purposes. As a result, a stockholder generally would be subject to tax on 100% of the fair market value of the dividend on the date the dividend is received by the stockholder in the same manner as a cash dividend, even though most of the dividend was paid in shares of our common stock.
The minimum distribution requirements applicable to RICs require us to distribute to our stockholders each year at least 90% of our investment company taxable income, or ICTI, as defined by the Code. Depending on the level of ICTI and net capital gain, if any, earned in a tax year, we may choose to carry forward ICTI in excess of current year distributions into the next tax year and pay a 4% U.S. federal excise tax on such excess. Any such carryover ICTI must be distributed before the end of the next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.
ICTI generally differs from net investment income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses. We may be required to recognize ICTI in certain circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments issued with warrants), we must include in ICTI each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in ICTI other amounts that we have not yet received in cash, such as (i) PIK interest income and (ii) interest income from investments that have been classified as non-accrual for financial reporting purposes. Interest income on non-accrual investments is not recognized for financial reporting purposes, but generally is recognized in ICTI. Because any original issue discount or other amounts accrued will be included in our ICTI for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the minimum distribution requirements, even though we will not have received and may not ever receive any corresponding cash amount. ICTI also excludes net unrealized appreciation or depreciation, as investment gains or losses are not included in taxable income until they are realized.
Recent Developments
Subsequent to March 31, 2023, we made approximately $2.7 million of new commitments, of which $2.2 million closed and funded. The $2.2 million of investments consists of $1.9 million of first lien senior secured debt investments and $0.3 million of subordinated debt investments. The weighted average yield of the debt investments was 11.2%. In addition, we funded $15.5 million of previously committed debt and equity facilities.
On May 4, 2023, the Board declared a quarterly distribution of $0.25 per share payable on June 14, 2023 to holders of record as of June 7, 2023.
Critical Accounting Policies and Use of Estimates
The preparation of our unaudited financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the periods covered by such financial statements. We have identified investment valuation and revenue recognition as our most critical accounting estimates. On an ongoing basis, we evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.
Valuation of Investments
The Adviser conducts the valuation of our investments, upon which our net asset value is primarily based, in accordance with its valuation policy, as well as established and documented processes and methodologies for determining the fair values of portfolio company investments on a recurring (at least quarterly) basis in accordance with the 1940 Act and FASB ASC Topic 820, *Fair Value Measurements and Disclosures (“*ASC Topic 820”). Our current valuation policy and processes were established by the Adviser and were approved by the Board.
As of March 31, 2023, our investment portfolio, valued at fair value in accordance with the Board-approved valuation policies, represented approximately 212% of our total net assets, as compared to approximately 205% of our total net assets as of December 31, 2022.
Under ASC Topic 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between a willing buyer and a willing seller at the measurement date. For our portfolio securities, fair value is generally the amount that we might reasonably expect to receive upon the current sale of the security. The fair value measurement assumes that the sale occurs in the principal market for the security, or in the absence of a principal market, in the most advantageous market for the security. If no market for the security exists or if we do not have access to the principal market, the security should be valued based on the sale occurring in a hypothetical market.
Under ASC Topic 820, there are three levels of valuation inputs, as follows:
Level 1 Inputs – include quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 Inputs – include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3 Inputs – include inputs that are unobservable and significant to the fair value measurement.
A financial instrument is categorized within the ASC Topic 820 valuation hierarchy based upon the lowest level of input to the valuation process that is significant to the fair value measurement. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized as Level 3 investments within the tables in the notes to our consolidated financial statements may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
Our investment portfolio includes certain debt and equity instruments of privately held companies for which quoted prices or other observable inputs falling within the categories of Level 1 and Level 2 are generally not available. In such cases, the Adviser determines the fair value of our investments in good faith primarily using Level 3 inputs. In certain cases, quoted prices or other observable inputs exist, and if so, the Adviser assesses the appropriateness of the use of these third-party quotes in determining fair value based on (i) its understanding of the level of actual transactions used by the broker to develop the quote and whether the quote was an indicative price or binding offer and (ii) the depth and consistency of broker quotes and the correlation of changes in broker quotes with underlying performance of the portfolio company.
There is no single standard for determining fair value in good faith, as fair value depends upon the specific circumstances of each individual investment. The recorded fair values of our Level 3 investments may differ significantly from fair values that would have been used had an active market for the securities existed. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the valuations currently assigned.
Investment Valuation Process
The Board must determine fair value in good faith for any or all of our investments for which market quotations are not readily available. The Board has designated the Adviser as valuation designee to perform the fair value determinations relating to the value of these assets. Barings has established a pricing committee that is, subject to the oversight of the Board, responsible for the approval, implementation and oversight of the processes and methodologies that relate to the pricing and valuation of assets we hold. Barings uses independent third-party providers to price the portfolio, but in the event an acceptable price cannot be obtained from an approved external source, Barings will utilize alternative methods in accordance with internal pricing procedures established by Barings’ pricing committee.
At least annually, Barings conducts reviews of the primary pricing vendors to validate that the inputs used in the vendors’ pricing process are deemed to be market observable. While Barings is not provided access to proprietary models of the vendors, the reviews have included on-site walkthroughs of the pricing process, methodologies and control procedures for each asset class and level for which prices are provided. The review also includes an examination of the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels and various durations, a process Barings continues to perform annually. In addition, the pricing vendors have an established challenge process in place for all security valuations, which facilitates identification and resolution of prices that fall outside expected ranges. Barings believes that the prices received from the pricing vendors are representative of prices that would be received to sell the assets at the measurement date (i.e., exit prices).
Our money market fund investments are generally valued using Level 1 inputs and our equity investments listed on an exchange or on the NASDAQ National Market System are valued using Level 1 inputs, using the last quoted sale price of that day. Our syndicated senior secured loans and structured product investments are generally valued using Level 2 inputs, which are generally valued at the bid quotation obtained from dealers in loans by an independent pricing service. Our middle-market, private debt and equity investments are generally valued using Level 3 inputs.
Independent Valuation
The fair value of loans and equity investments that are not syndicated or for which market quotations are not readily available, including middle-market loans, are generally submitted to independent providers to perform an independent valuation on those loans and equity investments as of the end of each quarter. Such loans and equity investments are initially held at cost, as that is a reasonable approximation of fair value on the acquisition date, and monitored for material changes that could affect the valuation (for example, changes in interest rates or the credit quality of the borrower). At the quarter end following that of the initial acquisition, such loans and equity investments are generally sent to a valuation provider which will determine the fair value of each investment. The independent valuation providers apply various methods (synthetic rating analysis, discounting cash flows, and re-underwriting analysis) to establish the rate of return a market participant would require (the “discount rate”) as of the valuation date, given market conditions, prevailing lending standards and the perceived credit quality of the issuer. Future expected cash flows for each investment are discounted back to present value using these discount rates in the discounted cash flow analysis. A range of values will be provided by the valuation provider and Barings will determine the point within that range that it will use. If the Barings pricing committee disagrees with the price range provided, it may make a fair value recommendation to Barings that is outside of the range provided by the independent valuation provider and the reasons therefore. In certain instances, we may determine that it is not cost-effective, and as a result is not in the stockholders’ best interests, to request an independent valuation firm to perform an independent valuation on certain investments. Such instances include, but are not limited to, situations where the fair value of the investment in the portfolio company is determined to be insignificant relative to the total investment portfolio.
Valuation Inputs
The Adviser’s valuation techniques are based upon both observable and unobservable pricing inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Adviser’s market assumptions. The Adviser’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. An independent pricing service provider is the preferred source of pricing a loan, however, to the extent the independent pricing service provider price is unavailable or not relevant and reliable, the Adviser will utilize alternative approaches such as broker quotes or manual prices. The Adviser attempts to maximize the use of observable inputs and minimize the use of unobservable inputs. The availability of observable inputs can vary from investment to investment and is affected by a wide variety of factors, including the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets and other characteristics particular to the security.
Valuation of Investments in Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity Fund LP
As Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity Fund LP are investment companies with no readily determinable fair values, the Adviser estimates the fair value of our investments in these entities using net asset value of each company and our ownership percentage as a practical expedient. The net asset value is determined in accordance with the specialized accounting guidance for investment companies.
Revenue Recognition
Interest and Dividend Income
Interest income, including amortization of premium and accretion of discount, is recorded on the accrual basis to the extent that such amounts are expected to be collected. Generally, when interest and/or principal payments on a loan become past due, or if we otherwise do not expect the borrower to be able to service its debt and other obligations, we will place the loan on non-accrual status and will generally cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to a restructuring such that the interest income is deemed to be collectible. The cessation of recognition of such interest will negatively impact the reported fair value of the investment. We write off any previously accrued and uncollected interest when it is determined that interest is no longer considered collectible.
Interest income from investments in the equity class of a collateralized loan obligation (“CLO”) security (typically subordinated notes) is recorded based upon an estimation of an effective yield to expected maturity utilizing assumed cash flows in accordance with ASC 325-40, Beneficial Interests in Securitized Financial Assets. We monitor the expected cash flows from these investments, including the expected residual payments, and the effective yield is determined and updated periodically. Any difference between the cash distribution received and the amount calculated pursuant to the effective interest method is recorded as an adjustment to the cost basis of such investments.
Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity is recorded on the ex-dividend date.
We may have to include interest income in our ICTI, including original issue discount income, from investments that have been classified as non-accrual for financial reporting purposes. Interest income on non-accrual investments is not recognized for financial reporting purposes, but generally is recognized in ICTI. As a result, we may be required to make a distribution to our stockholders in order to satisfy the minimum distribution requirements to maintain our RIC tax treatment, even though we will not have received and may not ever receive any corresponding cash amount. Additionally, any loss recognized by us for U.S. federal income tax purposes on previously accrued interest income will be treated as a capital loss.
Fee Income
Origination, facility, commitment, consent and other advance fees received in connection with the origination of a loan, or Loan Origination Fees, are recorded as deferred income and recognized as investment income over the term of the loan. Upon prepayment of a loan, any unamortized Loan Origination Fees are recorded as investment income. In the general course of our business, we receive certain fees from portfolio companies, which are non-recurring in nature. Such fees include loan prepayment penalties, structuring fees, covenant waiver fees and loan amendment fees, and are recorded as investment income when earned.
Fee income for the three months ended March 31, 2023 and 2022 was as follows:
($ in thousands)
| Recurring Fee Income: | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 |
|---|---|---|
| Amortization of loan origination fees | $1,672 | $1,327 |
| Management, valuation and other fees | 593 | (585) |
| Total Recurring Fee Income | 2,265 | 742 |
| Non-Recurring Fee Income: | ||
| Acceleration of unamortized loan origination fees | 345 | 196 |
| Advisory, loan amendment and other fees | 690 | 259 |
| Total Non-Recurring Fee Income | 1,035 | 455 |
| Total Fee Income | $3,300 | $1,197 |
129
Payment-in-Kind (PIK) Interest Income
We currently hold, and expect to hold in the future, some loans in our portfolio that contain PIK interest provisions. PIK interest, computed at the contractual rate specified in each loan agreement, is periodically added to the principal balance of the loan, rather than being paid to us in cash, and is recorded as interest income. Thus, the actual collection of PIK interest may be deferred until the time of debt principal repayment.
PIK interest, which is a non-cash source of income at the time of recognition, is included in our taxable income and therefore affects the amount we are required to distribute to our stockholders to maintain our tax treatment as a RIC for U.S. federal income tax purposes, even though we have not yet collected the cash. Generally, when current cash interest and/or principal payments on a loan become past due, or if we otherwise do not expect the borrower to be able to service its debt and other obligations, we will place the loan on non-accrual status and will generally cease recognizing PIK interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to a restructuring such that the interest income is deemed to be collectible. We write off any previously accrued and uncollected PIK interest when it is determined that the PIK interest is no longer collectible.
We may have to include in our ICTI, PIK interest income from investments that have been classified as non-accrual for financial reporting purposes. Interest income on non-accrual investments is not recognized for financial reporting purposes, but generally is recognized in ICTI. As a result, we may be required to make a distribution to our stockholders in order to satisfy the minimum distribution requirements, even though we will not have received and may not ever receive any corresponding cash amount.
Unused Commitments
In the normal course of business, we are party to financial instruments with off-balance sheet risk, consisting primarily of unused commitments to extend financing to our portfolio companies. Since commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. As of March 31, 2023 and December 31, 2022, we believed that we had adequate financial resources to satisfy our unfunded commitments. The balances of unused commitments to extend financing as of March 31, 2023 and December 31, 2022 were as follows:
| Portfolio Company ($ in thousands) | Investment Type | March 31, 2023 | December 31, 2022 |
|---|---|---|---|
| Accurus Aerospace Corporation(1)(2) | Revolver | $922 | $1,152 |
| AlliA Insurance Brokers NV(1)(2)(3) | Delayed Draw Term Loan | 2,055 | — |
| Amtech LLC(1) | Delayed Draw Term Loan | 1,527 | 1,527 |
| Amtech LLC(1) | Revolver | 682 | 545 |
| AnalytiChem Holding GmbH(1)(2)(3) | Bridge Revolver | 373 | 366 |
| APC1 Holding(1)(3) | Delayed Draw Term Loan | — | 354 |
| Aquavista Watersides 2 LTD(1)(2)(4) | Capex / Acquisition Facility | 2,155 | 2,543 |
| Arc Education(1)(3) | Delayed Draw Term Loan | 1,934 | 1,900 |
| Argus Bidco Limited(1)(2)(4) | CAF Term Loan | 674 | 789 |
| Argus Bidco Limited(1)(2)(4) | RCF Bridge Term Loan | 172 | 168 |
| ASC Communications, LLC | Revolver | 1,089 | 1,089 |
| Astra Bidco Limited(1)(4) | Delayed Draw Term Loan | 901 | 876 |
| ATL II MRO Holdings, Inc.(1) | Revolver | 1,667 | 1,667 |
| Avance Clinical Bidco Pty Ltd(1)(5) | Delayed Draw Term Loan | 1,280 | 1,295 |
| Azalea Buyer, Inc.(1) | Delayed Draw Term Loan | 962 | 962 |
| Azalea Buyer, Inc.(1) | Revolver | 481 | 481 |
| Bariacum S.A(1)(3) | Acquisition Facility | 2,064 | 2,028 |
| Beyond Risk Management, Inc.(1)(2) | Delayed Draw Term Loan | 2,423 | 2,423 |
| Biolam Group(1)(2)(3) | Delayed Draw Term Loan | 4,152 | 4,783 |
| Black Angus Steakhouses, LLC(1) | Delayed Draw Term Loan | 417 | 417 |
| Bounteous, Inc.(1)(2) | Delayed Draw Term Loan | 2,840 | 2,840 |
130
| Portfolio Company ($ in thousands) | Investment Type | March 31, 2023 | December 31, 2022 |
|---|---|---|---|
| Brightpay Limited(1)(2)(3) | Delayed Draw Term Loan | 138 | 135 |
| BrightSign LLC(1) | Revolver | — | 1,329 |
| CAi Software, LLC(1)(2) | Revolver | 943 | 943 |
| Canadian Orthodontic Partners Corp.(1)(2)(6) | Delayed Draw Term Loan | — | 110 |
| Catawba River Limited(1)(2)(4) | Structured Junior Note | 12,999 | 12,635 |
| Centralis Finco S.a.r.l.(1)(3) | Incremental CAF Term Loan | 921 | 1,028 |
| CGI Parent, LLC(1)(2) | Revolver | 1,653 | 1,653 |
| Classic Collision (Summit Buyer, LLC)(1) | Delayed Draw Term Loan | 78 | 78 |
| Comply365, LLC(1) | Revolver | 1,101 | 935 |
| Coyo Uprising GmbH(1)(3) | Delayed Draw Term Loan | 427 | 419 |
| CSL Dualcom(1)(4) | Capex / Acquisition Term Loan | 146 | 142 |
| DataServ Integrations, LLC(1) | Revolver | 481 | 481 |
| DecksDirect, LLC(1) | Revolver | 218 | 218 |
| DISA Holdings Corp.(1) | Delayed Draw Term Loan | 1,368 | 1,368 |
| DISA Holdings Corp.(1) | Revolver | 429 | 416 |
| DreamStart Bidco SAS (d/b/a SmartTrade)(1)(2)(3) | Acquisition Facility | — | 579 |
| Dune Group(1)(2)(3) | Delayed Draw Term Loan | 635 | 624 |
| Dwyer Instruments, Inc.(1) | Delayed Draw Term Loan | 5,165 | 5,164 |
| Eclipse Business Capital, LLC(1) | Revolver | 18,364 | 17,455 |
| EMI Porta Holdco LLC(1)(2) | Delayed Draw Term Loan | 9,272 | 9,272 |
| EMI Porta Holdco LLC(1)(2) | Revolver | 1,092 | 1,471 |
| EPS NASS Parent, Inc.(1) | Delayed Draw Term Loan | 257 | 257 |
| eShipping, LLC(1) | Delayed Draw Term Loan | 1,650 | 1,650 |
| eShipping, LLC(1) | Revolver | 1,486 | 1,486 |
| Eurofins Digital Testing International LUX Holding SARL(1)(2)(3) | Delayed Draw Term Loan | 2,686 | 2,639 |
| Eurofins Digital Testing International LUX Holding SARL(1)(2)(3) | Delayed Draw Term Loan | 537 | 528 |
| Events Software BidCo Pty Ltd(1)(2) | Delayed Draw Term Loan | 640 | 640 |
| Express Wash Acquisition Company, LLC(1)(2) | Revolver | 115 | 115 |
| F24 (Stairway BidCo GmbH)(1)(2)(3) | Acquisition Term Loan | 230 | 246 |
| Faraday(1)(2)(3) | Delayed Draw Term Loan | 974 | — |
| Fineline Technologies, Inc.(1) | Delayed Draw Term Loan | — | 180 |
| Footco 40 Limited(1)(2)(4) | Delayed Draw Term Loan | 556 | 766 |
| Fortis Payment Systems, LLC(1)(2) | Delayed Draw Term Loan | 925 | 925 |
| FragilePak LLC(1) | Delayed Draw Term Loan | 2,354 | 2,354 |
| GB Eagle Buyer, Inc.(1)(2) | Revolver | 2,581 | 2,581 |
| Global Academic Group Limited(1)(7) | Term Loan | 446 | 451 |
| GPZN II GmbH(1)(2)(3) | CAF Term Loan | — | 560 |
| Greenhill II BV(1)(3) | Capex Acquisition Facility | 260 | 255 |
| Groupe Product Life(1)(3) | Delayed Draw Term Loan | 449 | 441 |
| Gusto Aus BidCo Pty Ltd(1)(5) | Delayed Draw Term Loan | 220 | 223 |
| HeartHealth Bidco Pty Ltd(1)(5) | Delayed Draw Term Loan | 309 | 313 |
| Heartland Veterinary Partners, LLC(1) | Delayed Draw Term Loan | 267 | 267 |
| Heavy Construction Systems Specialists, LLC(1) | Revolver | 2,632 | 2,632 |
| HEKA Invest(1)(2)(3) | Delayed Draw Term Loan | 565 | 555 |
| HTI Technology & Industries(1)(2) | Delayed Draw Term Loan | 2,045 | 2,045 |
131
| Portfolio Company ($ in thousands) | Investment Type | March 31, 2023 | December 31, 2022 |
|---|---|---|---|
| HTI Technology & Industries(1)(2) | Revolver | 1,364 | 1,364 |
| HW Holdco, LLC (Hanley Wood LLC)(1) | Delayed Draw Term Loan | 556 | 913 |
| Innovad Group II BV(1)(2)(3) | Delayed Draw Term Loan | 1,284 | 1,261 |
| INOS 19-090 GmbH(1)(3) | Acquisition Facility | 2,422 | 2,380 |
| Interstellar Group B.V.(1)(3) | Delayed Draw Term Loan | 1,334 | 1,310 |
| Interstellar Group B.V.(1)(3) | Delayed Draw Term Loan | 56 | 55 |
| Isolstar Holding NV (IPCOM)(1)(3) | Delayed Draw Term Loan | 757 | 744 |
| ITI Intermodal, Inc.(1)(2) | Delayed Draw Term Loan | — | 103 |
| ITI Intermodal, Inc.(1)(2) | Delayed Draw Term Loan | 4,249 | — |
| ITI Intermodal, Inc.(1)(2) | Revolver | 857 | 118 |
| Jaguar Merger Sub Inc.(1) | Delayed Draw Term Loan | — | 422 |
| Jaguar Merger Sub Inc.(1) | Revolver | — | 490 |
| Jocassee Partners LLC | Joint Venture | 65,000 | 65,000 |
| Jon Bidco Limited(1)(7) | Capex & Acquisition Facility | 1,425 | 1,441 |
| Jones Fish Hatcheries & Distributors LLC(1)(2) | Revolver | 418 | 418 |
| Kano Laboratories LLC(1) | Delayed Draw Term Loan | 153 | 153 |
| Kano Laboratories LLC(1) | Delayed Draw Term Loan | 2,830 | 2,830 |
| Kemmerer Operations LLC(1) | Delayed Draw Term Loan | — | 908 |
| Lambir Bidco Limited(1)(2)(3) | Delayed Draw Term Loan | 1,797 | 1,766 |
| Lattice Group Holdings Bidco Limited(1)(2) | Delayed Draw Term Loan | 255 | 298 |
| LeadsOnline, LLC(1) | Revolver | 2,603 | 2,603 |
| Lifestyle Intermediate II, LLC(1)(2) | Revolver | 2,500 | 2,500 |
| LivTech Purchaser, Inc.(1)(2) | Delayed Draw Term Loan | 138 | 138 |
| Marmoutier Holding B.V.(1)(2)(3) | Delayed Draw Term Loan | 24 | 24 |
| Marmoutier Holding B.V.(1)(2)(3) | Revolver | 108 | 106 |
| Marshall Excelsior Co.(1) | Revolver | 55 | 413 |
| MC Group Ventures Corporation(1) | Delayed Draw Term Loan | 296 | 296 |
| Mercell Holding AS(1)(8) | Capex Acquisition Facility | 750 | 797 |
| Modern Star Holdings Bidco Pty Limited(1)(2)(5) | Term Loan | 956 | 968 |
| Murphy Midco Limited(1)(2)(4) | Delayed Draw Term Loan | 361 | 407 |
| Narda Acquisitionco., Inc.(1)(2) | Revolver | 1,180 | 1,180 |
| NeoxCo(1)(2)(3) | Delayed Draw Term Loan | 489 | — |
| Nexus Underwriting Management Limited(1)(2)(4) | Acquisition Facility | 374 | 443 |
| NF Holdco, LLC(1)(2) | Revolver | 1,105 | — |
| Novotech Aus Bidco Pty Ltd(1)(2) | Capex & Acquisition Facility | 809 | 809 |
| NPM Investments 28 BV(1)(3) | Delayed Draw Term Loan | 471 | 463 |
| OA Buyer, Inc.(1) | Revolver | 1,331 | 1,331 |
| OAC Holdings I Corp(1) | Revolver | 254 | 607 |
| Omni Intermediate Holdings, LLC(1)(2) | Delayed Draw Term Loan | — | 2,289 |
| OSP Hamilton Purchaser, LLC(1)(2) | Revolver | 384 | 187 |
| PDQ.Com Corporation(1) | Delayed Draw Term Loan | 6,885 | 6,885 |
| Polara Enterprises, L.L.C.(1) | Revolver | 545 | 545 |
| Premium Invest(1)(3) | Delayed Draw Term Loan | 2,933 | 2,882 |
| ProfitOptics, LLC(1) | Revolver | 306 | 484 |
| Protego Bidco B.V.(1)(2)(3) | Delayed Draw Term Loan | 807 | 792 |
| PSP Intermediate 4, LLC(1)(2)(3) | Delayed Draw Term Loan | 740 | 727 |
| Qualified Industries, LLC(1)(2) | Revolver | 242 | — |
132
| Portfolio Company ($ in thousands) | Investment Type | March 31, 2023 | December 31, 2022 |
|---|---|---|---|
| R1 Holdings, LLC(1) | Delayed Draw Term Loan | 1,820 | 2,623 |
| R1 Holdings, LLC(1) | Revolver | 1,601 | 1,601 |
| RA Outdoors, LLC(1)(2) | Revolver | 864 | 1,235 |
| Randys Holdings, Inc.(1)(2) | Delayed Draw Term Loan | 4,412 | 4,412 |
| Randys Holdings, Inc.(1)(2) | Revolver | 1,513 | 1,571 |
| Rep Seko Merger Sub LLC(1) | Delayed Draw Term Loan | 579 | 725 |
| Reward Gateway (UK) Ltd(1)(2)(4) | Acquisition Facility | 617 | 600 |
| Rhondda Financing No. 1 DAC(1)(2)(4) | Structured Junior Note | 22,914 | — |
| Rocade Holdings LLC | Preferred Equity | 40,000 | — |
| Royal Buyer, LLC(1) | Revolver | 1,340 | 1,340 |
| Royal Buyer, LLC(1) | Delayed Draw Term Loan | 2,082 | 2,209 |
| RTIC Subsidiary Holdings, LLC(1)(2) | Revolver | 1,587 | 2,381 |
| Sanoptis S.A.R.L.(1)(2)(3) | Acquisition Capex Facility | 846 | 1,751 |
| Sanoptis S.A.R.L.(1)(2)(9) | CAF Delayed Draw Term Loan | 445 | — |
| SBP Holdings LP(1)(2) | Delayed Draw Term Loan | 1,469 | — |
| SBP Holdings LP(1)(2) | Revolver | 887 | — |
| Scaled Agile, Inc.(1)(2) | Delayed Draw Term Loan | 416 | 416 |
| Scaled Agile, Inc.(1) | Revolver | 336 | 336 |
| Scout Bidco B.V.(1)(3) | Delayed Draw Term Loan | 2,311 | 2,270 |
| Scout Bidco B.V.(1)(3) | Revolver | 1,049 | 1,030 |
| Security Holdings B.V.(1)(2)(3) | Delayed Draw Term Loan | 2,173 | 2,134 |
| Security Holdings B.V.(1)(2)(3) | Revolver | 1,086 | 1,067 |
| Sereni Capital NV(1)(2)(3) | Delayed Draw Term Loan | 1,599 | — |
| Sereni Capital NV(1)(2)(3) | Term Loan | — | 109 |
| Smartling, Inc.(1)(2) | Delayed Draw Term Loan | 1,978 | 1,978 |
| Smartling, Inc.(1)(2) | Revolver | 1,176 | 1,176 |
| Smile Brands Group, Inc.(1)(2) | Delayed Draw Term Loan | — | 38 |
| Soho Square III Debtco II SARL(1)(4) | Delayed Draw Term Loan | 3,478 | 3,383 |
| Solo Buyer, L.P.(1)(2) | Revolver | 1,995 | 1,995 |
| Sparus Holdings, LLC (f/k/a Sparus Holdings, Inc.)(1) | Delayed Draw Term Loan | 399 | 666 |
| Sparus Holdings, LLC (f/k/a Sparus Holdings, Inc.)(1) | Revolver | 141 | 156 |
| Spatial Business Systems LLC(1) | Delayed Draw Term Loan | 7,500 | 7,500 |
| Spatial Business Systems LLC(1) | Revolver | 1,406 | 1,406 |
| SSCP Pegasus Midco Limited(1)(4) | Delayed Draw Term Loan | 4,794 | 4,664 |
| Superjet Buyer, LLC(1) | Revolver | 1,825 | 1,825 |
| Syntax Systems Ltd(1)(2) | Delayed Draw Term Loan | 1,933 | 1,933 |
| Syntax Systems Ltd(1)(2) | Revolver | 202 | 337 |
| Tank Holding Corp(1) | Revolver | 625 | 698 |
| Tanqueray Bidco Limited(1)(2)(4) | Capex Facility | 1,118 | 1,088 |
| Techone B.V.(1)(3) | Revolver | 310 | 203 |
| Tencarva Machinery Company, LLC(1) | Revolver | 1,129 | 1,129 |
| The Caprock Group, Inc. (aka TA/TCG Holdings, LLC)(1) | Delayed Draw Term Loan | 2,811 | 2,811 |
| The Caprock Group, Inc. (aka TA/TCG Holdings, LLC)(1) | Revolver | 827 | 827 |
| The Cleaver-Brooks Company, Inc.(1) | Revolver | 3,229 | 2,826 |
| The Hilb Group, LLC(1)(2) | Delayed Draw Term Loan | 858 | 1,182 |
| Trader Corporation(1)(6) | Revolver | 345 | 345 |
| TSYL Corporate Buyer, Inc.(1) | Delayed Draw Term Loan | 1,681 | 1,681 |
133
| Portfolio Company ($ in thousands) | Investment Type | March 31, 2023 | December 31, 2022 |
|---|---|---|---|
| TSYL Corporate Buyer, Inc.(1) | Revolver | 177 | 177 |
| Turbo Buyer, Inc.(1)(2) | Delayed Draw Term Loan | 1,350 | 1,350 |
| Union Bidco Limited(1)(2)(4) | Acquisition Facility | 80 | 78 |
| United Therapy Holding III GmbH(1)(2)(3) | Acquisition Facility | 672 | 1,170 |
| Unither (Uniholding)(1)(2)(3) | Delayed Draw Term Loan | 471 | — |
| USLS Acquisition, Inc.(f/k/a US Legal Support, Inc.)(1)(2) | Delayed Draw Term Loan | 3,629 | 3,629 |
| W2O Holdings, Inc.(1) | Delayed Draw Term Loan | — | 2,622 |
| Waccamaw River(2) | Joint Venture | 2,480 | 2,480 |
| Whitcraft Holdings, Inc.(1)(2) | Revolver | 1,886 | — |
| Woodland Foods, Inc.(1)(2) | Line of Credit | 456 | 456 |
| WWEC Holdings III Corp(1)(2) | Delayed Draw Term Loan | 3,106 | 3,106 |
| WWEC Holdings III Corp(1)(2) | Revolver | 1,367 | 1,366 |
| Xeinadin Bidco Limited(1)(2)(4) | CAF Term Loan | 3,196 | 3,109 |
| ZB Holdco LLC(1)(2) | Delayed Draw Term Loan | — | 1,352 |
| ZB Holdco LLC(1) | Revolver | 845 | 845 |
| Zeppelin Bidco Limited(1)(2)(4) | Capex / Acquisition Facility | 2,587 | 2,516 |
| Total unused commitments to extend financing | $371,795 | $308,532 |
(1) The Adviser’s estimate of the fair value of the current investments in these portfolio companies includes an analysis of the fair value of any unfunded commitments.
(2) Represents a commitment to extend financing to a portfolio company where one or more of our current investments in the portfolio company are carried at less than cost.
(3) Actual commitment amount is denominated in Euros. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
(4) Actual commitment amount is denominated in British pounds sterling. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
(5) Actual commitment amount is denominated in Australian dollars. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
(6) Actual commitment amount is denominated in Canadian dollars. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
(7) Actual commitment amount is denominated in New Zealand dollars. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
(8) Actual commitment amount is denominated in Norwegian kroner. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
(9) Actual commitment amount is denominated in Swiss francs. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
In the normal course of business, we guarantee certain obligations in connection with our portfolio companies (in particular, certain controlled portfolio companies). Under these guarantee arrangements, payments may be required to be made to third parties if such guarantees are called upon or if the portfolio companies were to default on their related obligations, as applicable. As of March 31, 2023 and December 31, 2022, we had guaranteed €9.9 million ($10.8 million U.S. dollars and $10.6 million U.S. dollars, respectively) relating to credit facilities among Erste Bank and MVC Automotive Group Gmbh, or MVC Auto that mature in December 2025. We would be required to make payments to Erste Bank if MVC Auto were to default on their related payment obligations. None of the credit facility guarantees are recorded as a liability on our Unaudited and Audited Consolidated Balance Sheets. As such, the credit facility liabilities are considered in the valuation of our investments in MVC Auto. The guarantees denominated in foreign currencies were translated into U.S. dollars based on the spot rate at the relevant balance sheet date.
Market risk
As filed, 8,331 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are subject to market risk. Market risk includes risks that arise from changes in interest rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. The fair value of securities held by us may decline in response to certain events, including those directly involving the companies we invest in; conditions affecting the general economy; overall market changes; global pandemics; legislative reform; local, regional, national or global political, social or economic instability; and interest rate fluctuations.
In addition, we are subject to interest rate risk. Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire and originate loans and securities and the value of our investment portfolio. Our net investment income is affected by fluctuations in various interest rates, including LIBOR, EURIBOR, BBSY, STIBOR, CDOR, SOFR, SONIA, SARON, NIBOR and BKBM. Our risk management systems and procedures are designed to identify and analyze our risk, to set appropriate policies and limits and to continually monitor these risks. We regularly measure exposure to interest rate risk and determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates. As of March 31, 2023, we were not a party to any interest rate hedging arrangements.
In March 2021, the U.K.’s Financial Conduct Authority publicly announced that all U.S. Dollar LIBOR settings will either cease to be provided by any administrator or no longer be representative (i) immediately after December 31, 2021 for one-week and two-month U.S. Dollar LIBOR settings and (ii) immediately after June 30, 2023 for the remaining U.S. Dollar LIBOR settings. Although most U.S. dollar LIBOR rates will continue to be published through June 30, 2023, the Financial Conduct Authority no longer compels panel banks to continue to contribute to LIBOR and the Federal Reserve Board, the Office of the Comptroller of the Currency, and the Federal Deposit Insurance Corporation have encouraged banks to cease entering into new contracts that use U.S. dollar LIBOR as a reference rate. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, supports replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate, or SOFR, a new index calculated by short-term repurchase agreements backed by Treasury securities. Some regulators have prohibited the use of any LIBOR benchmarks in new contracts and have required that regulated entities transition existing contracts to another benchmark prior to June 30, 2023.
Although settings of such LIBOR benchmarks may continue to be available, such prohibitions and requirements may adversely affect the value of floating-rate debt securities in our portfolio or issued by us. Moreover, at this time, no consensus exists as to what rate or rates will become accepted alternatives to LIBOR. Although there are an increasing number of issuances utilizing SOFR or the Sterling Over Night Index Average, or SONIA, an alternative reference rate that is based on transactions, these alternative reference rates may not attain market acceptance as replacements for LIBOR. All of our loan agreements with our portfolio companies include fallback language in the event that LIBOR becomes unavailable. This language generally either includes a clearly defined alternative reference rate after LIBOR’s discontinuation or provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. In addition, any further changes or reforms to the determination or supervision of LIBOR may result in a sudden or prolonged increase or decrease in reported LIBOR, which could have an adverse impact on the market value for or value of any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us and could have a material adverse effect on our business, financial condition and results of operations.
The transition away from LIBOR to alternative reference rates is complex and could have a material adverse effect on our business, financial condition and results of operations, including as a result of any changes in the pricing of our investments, changes to the documentation for certain of our investments and the pace of such changes, disputes and other actions regarding the interpretation of current and prospective loan documentation or modifications to processes and systems.
The U.S. Federal Reserve is currently embarking on an aggressive campaign of raising interest rates to address significant and persistent inflation. The goal of these interest rate increases is to slow economic growth and reduce price pressure. There is a significant chance that this central bank tightening cycle could force the U.S. into a recession, at which point interest rates and base rates would likely decrease. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in SOFR are not offset by a corresponding increase in the spread over SOFR that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities tied to SOFR.
As of March 31, 2023, approximately $1,989.6 million (principal amount) of our debt portfolio investments bore interest at variable rates, which generally are LIBOR-based or SOFR-based (or based on an equivalent applicable currency rate), and many of which are subject to certain floors.
Based on our March 31, 2023 Unaudited Consolidated Balance Sheet, the following table shows the annual impact on net income of hypothetical base rate changes in interest rates on our debt investments and borrowings (considering interest rate floors for variable rate instruments) assuming no changes in our investment and borrowing structure:
| (in thousands) Basis Point Change(1) | Interest Income | Interest Expense | Net Income(2) |
|---|---|---|---|
| Up 300 basis points | $59,688 | $23,073 | $36,615 |
| Up 200 basis points | 39,792 | 15,382 | 24,410 |
| Up 100 basis points | 19,896 | 7,691 | 12,205 |
| Down 25 basis points | (4,974) | (1,923) | (3,051) |
| Down 50 basis points | (9,948) | (3,846) | (6,102) |
(1) Excludes the impact of foreign currency exchange.
(2) Excludes the impact of income based fees. See Note 2 to our Unaudited Consolidated Financial Statements for more information on the income based fees.
We may also have exposure to foreign currencies related to certain investments. Such investments are translated into U.S. dollars based on the spot rate at the relevant balance sheet date, exposing us to movements in the exchange rate. In order to reduce our exposure to fluctuations in exchange rates, we generally borrow in local foreign currencies under the February 2019 Credit Facility to finance such investments. As of March 31, 2023, we had borrowings denominated in Swedish krona of 12.8kr million ($1.2 million U.S. dollars) with an interest rate of 5.000%, borrowings denominated in British pounds sterling of £68.6 million ($84.8 million U.S. dollars) with an interest rate of 5.960% and borrowings denominated in Euros of €138.6 million ($150.6 million U.S. dollars) with an interest rate of 4.625%.
Controls and procedures
As filed, 1,855 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2023. It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the first quarter of 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 4,484 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
You should carefully consider the risks described below and in Item 1A entitled “Risk Factors” in Part 1 of our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023, and all other information contained in this Quarterly Report on Form 10-Q, including our interim financial statements and the related notes thereto, before making a decision to purchase our securities. The risks and uncertainties referenced herein and in our most recent Annual Report on Form 10-K are not the only ones facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may have a material adverse effect on our business, financial condition and/or operating results, as well as the market price of our securities.
Other than as set forth below, there have been no material changes during the three months ended March 31, 2023 to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022. If any of such risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, the market price of our securities could decline, and you may lose all or part of your investment.
We, the Adviser, and our portfolio companies may maintain cash balances at financial institutions that exceed federally insured limits and may otherwise be materially affected by adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties.
Our cash and our Adviser’s cash is held in accounts at U.S. banking institutions that we believe are of high quality. Cash held by us, our Adviser and by our portfolio companies in non-interest-bearing and interest-bearing operating accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limitations. In addition, actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects.
Although we and our Adviser assess our and our portfolio companies’ banking relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our respective current and projected future business operations could be significantly impaired by factors that affect us, our Adviser or our portfolio companies, the financial institutions with which we, our Adviser or our portfolio companies have arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.
In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Adviser, or our portfolio companies to acquire financing on acceptable terms or at all.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $19.3m | us-gaap:InterestExpense |
| Net income | 3 months2023-01-01 to 2023-03-31 | $39.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $0.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 107,916,166 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | −$92.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 3 months2023-01-01 to 2023-03-31 | $27.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2023-01-01 to 2023-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2023-03-31 | $2.73bn | us-gaap:Assets |
| Total liabilities | At period end2023-03-31 | $1.52bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $719.4m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-03-31 | $1.21bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001379785-23-000028. Last ingested by Listed: Nov 9, 2026, 19:13 ET. Listed shows no prices and gives no investment advice.